Public Company Healthcare

CVS Health

Woonsocket, Rhode Island, United States

CVS Health is the leading health solutions company delivering care through local presence, digital channels, and a large workforce across the U.S., helping people manage chronic diseases, stay compliant with medications, navigate the health care system, and access affordable health and wellness services.

Focus Areas
Retail Pharmacy, Specialty Pharmacy, Pharmacy Benefit Management (PBM)
Website
cvshealth.com

Tracked deals

3

3 tracked deals across 2022-2023.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Growth capital

2 growth capital · 1 buyout

CVS Health Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for CVS Health. 1 2022 2 2023

Supporting Data

Recent Transactions

  • CVS Health Leads $25M Growth Round in Array Behavioral Care
    June 1, 2023
    Buyer
    CVS Health, Wells Fargo Strategic Capital, Health Velocity Capital, Harbour Point Capital, HLM Venture Partners, OCA Ventures, OSF HealthCare
    Target
    Array Behavioral Care
    Industry
    Healthcare Services
    Location
    Illinois, United States
    Type
    Growth capital

    Array Behavioral Care closed a $25 million equity financing round led by CVS Health, with participation from existing investors including Wells Fargo Strategic Capital, Health Velocity Capital, Harbour Point Capital, HLM Venture Partners, OCA Ventures, and OSF HealthCare. The capital will be used to scale Array’s virtual psychiatry and therapy services, enhance technology and operations, and expand access through deeper collaboration with CVS Health.

  • CVS Acquires Hoover Pharmacy
    March 28, 2023
    Buyer
    CVS Pharmacy (CVS Health)
    Target
    Hoover Pharmacy
    Seller
    Hoover Pharmacy ownership team
    Industry
    Healthcare Services
    Location
    California, United States
    Type
    Buyout

    CVS has acquired Hoover Pharmacy, a specialty and retail pharmacy based in the San Francisco Bay Area that served Stanford Medical Campus patients. Hoover Pharmacy's patient files and dispensing services will be transferred to CVS, with patients receiving prescriptions at their local Palo Alto CVS branch.

  • General Atlantic Leads $300M Series D Growth Round in Biofourmis
    April 26, 2022
    Buyer
    General Atlantic, CVS Health, SoftBank Vision Fund 2, Openspace Ventures, MassMutual Ventures, Sequoia Capital, EDBI
    Target
    Biofourmis
    Industry
    Healthcare Services
    Location
    Massachusetts, United States
    Type
    Growth capital

    Biofourmis, a virtual care and digital medicine company headquartered in Needham/Boston, raised $300 million in a Series D growth round led by General Atlantic, with participation from CVS Health and existing investors including SoftBank Vision Fund 2, Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. The capital will be used to scale Biofourmis’ Care@Home virtual care platform, expand virtual specialty care and digital therapeutics programs, and accelerate clinical trials and partnerships in value-based care.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 3 tracked deals by CVS Health. Acquisitions in California 1 tracked deal by CVS Health. Acquisitions in Illinois 1 tracked deal by CVS Health. Acquisitions in Massachusetts 1 tracked deal by CVS Health.

Related articles

Selling a company? Get in front of buyers like CVS Health

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →